Today: 9 April 2026
Subscribe
Browse Category

Reddit 30 October 2025 - 13 December 2025

Reddit (RDDT) Stock: What to Know Before the Market Opens on December 8, 2025

Reddit (RDDT) Stock: What to Know Before the Market Opens on December 8, 2025

Reddit shares closed at $234.11 on Friday, up 5.1%, with a market cap near $44.4 billion. Institutional investors, including Northwestern Mutual and Amundi, sharply increased their holdings, while insiders sold about $83 million in stock this quarter. The company reported trailing 12-month revenue of $1.9 billion and a forward P/E near 70. Volatility remains high ahead of Monday’s session.
8 December 2025
··
Reddit (RDDT) Stock Outlook on December 6, 2025: Can the Rally Run After a 450% Post‑IPO Surge?

Reddit (RDDT) Stock Outlook on December 6, 2025: Can the Rally Run After a 450% Post‑IPO Surge?

Reddit Inc. shares closed at $234.11 on Dec. 5, up 5.1%, after rebounding sharply from a post-September slump. The company reported Q3 net income of $163 million on $585 million in revenue, with daily active users rising 19% to 116 million. Reddit’s stock has surged over 450% since its March 2024 IPO. Market cap stands near $44 billion.
6 December 2025
···
Reddit RDDT Stock Rockets 200% in 2025 After AI Ad Boom, TikTok Sell-Off and Analyst Upgrades

Reddit Stock Rockets: AI Deals, Earnings Beat and What’s Next for RDDT

Reddit shares fell 5.7% to about $199 intraday Oct. 30, ahead of Q3 earnings. The stock is up 90% from a year ago, but down 14% in the past month after hitting a $282.81 high in September. Analysts expect Q3 revenue near $539 million and EPS of $0.52. Reddit recently sued Perplexity AI for alleged data theft and expanded AI features on its platform.
30 October 2025
····
1 2

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop